Abstract
This article has no abstract.
This article has no abstract.
I. L. Bonta and C. J. de Vos, “Presence of a slow-contraction inducing material in fluid collected from the rat paw oedema induced by serotonin,” Experientia, vol. 21, no. 1, pp. 34–35, 1965.
View at: Publisher Site | Google ScholarI. L. Bonta, N. Bhargava, and C. J. de Vos, “Specific oedema-inhibiting property of a natural anti-inflammatory factor collected from inflamed tissue,” Experientia, vol. 26, no. 7, pp. 759–760, 1970.
View at: Publisher Site | Google ScholarD. W. Hall and I. L. Bonta, “The biphasic response of the isolated guinea-pig ileum by bradykinin,” European Journal of Pharmacology, vol. 21, no. 2, pp. 147–154, 1973.
View at: Publisher Site | Google ScholarA. L. Frankhuijzen and I. L. Bonta, “Role of prostaglandins in tone and effector reactivity of the isolated rat stomach preparation,” European Journal of Pharmacology, vol. 31, no. 1, pp. 44–52, 1975.
View at: Publisher Site | Google ScholarH. Bult and I. L. Bonta, “Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides,” Nature, vol. 264, no. 5585, pp. 449–451, 1976.
View at: Publisher Site | Google ScholarJ. E. Vincent, I. L. Bonta, and F. J. Zijlstra, “Platelets and mediators in the carrageenin rat paw oedema,” Agents and Actions. Supplements, vol. 2, pp. 41–46, 1977.
View at: Google ScholarM. J. Parnham, I. L. Bonta, and M. J. P. Adolfs, “Cyclic AMP and prostaglandin E in perfusates of rat hind paws during the development of adjuvant arthritis,” Annals of the Rheumatic Diseases, vol. 37, no. 3, pp. 218–224, 1978.
View at: Google ScholarP. C. Bragt and I. L. Bonta, “In vivo metabolism of [1-]arachidonic acid during different phases of granuloma development in the rat,” Biochemical Pharmacology, vol. 28, no. 10, pp. 1581–1586, 1979.
View at: Publisher Site | Google ScholarF. J. Zijlstra, I. L. Bonta, M. J. P. Adolfs, and J. E. Vincent, “Isoprenaline inhibits the leukotriene -induced release of thromboxane from guinea pig lung parenchyma,” European Journal of Pharmacology, vol. 76, no. 2-3, pp. 297–298, 1981.
View at: Publisher Site | Google ScholarE. J. Schenkelaars and I. L. Bonta, “-adrenoceptor agonists reverse the leukotriene -induced release response of macrophages,” European Journal of Pharmacology, vol. 107, no. 1, pp. 65–70, 1984.
View at: Publisher Site | Google ScholarR. J. Ouwendijk, F. J. Zijlstra, J. H. Wilson, J. E. Vincent, and I. L. Bonta, “Production of leukotrienes and prostaglandins by human ascites cells,” European Journal of Clinical Investigation, vol. 15, no. 6, pp. 327–331, 1985.
View at: Google ScholarJ. A. Van Hilten, G. R. Elliott, and I. L. Bonta, “Specific lipoxygenase inhibition reverses macrophage cytotasis towards P815 tumor cells in vitro induced by the calcium ionophore A23187,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 34, no. 3, pp. 187–192, 1988.
View at: Publisher Site | Google ScholarG. R. Elliott, C. Tak, C. Pellens, S. Ben-Efraim, and I. L. Bonta, “Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is inhibited by both prostaglandin and nordihydroguaiaretic acid, a lipoxygenase inhibitor,” Cancer Immunology Immunotherapy, vol. 27, no. 2, pp. 133–136, 1988.
View at: Publisher Site | Google ScholarM. W. J. A. Fieren, G. J. C. M. Van den Bemd, and I. L. Bonta, “Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 in vitro during infectious peritonitis,” European Journal of Clinical Investigation, vol. 20, no. 4, pp. 453–457, 1990.
View at: Google ScholarF. D. Beusenberg, A. van Schaik, J. G. C. van Amsterdam, and I. L. Bonta, “Involvement of eicosanoids in platelet-activating factor-induced modulation of adenylyl cyclase activity in alveolar macrophages,” Journal of Lipid Mediators, vol. 3, no. 3, pp. 301–309, 1991.
View at: Google ScholarI. M. Garrelds, F. J. Zijlstra, C. J. A. M. Tak, I. L. Bonta, I. Beckmann, and S. Ben-Efraim, “A comparison between two methods for measuring tumor necrosis factor in biological fluids,” Agents and Actions, vol. 38, pp. C89–C91, 1993.
View at: Google ScholarW. M. Pruimboom, A. P. M. van Dijk, C. J. A. M. Tak, I. L. Bonta, J. H. P. Wilson, and F. J. Zijlstra, “Production of inflammatory mediators by human macrophages obtained from ascites,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 50, no. 4, pp. 183–192, 1994.
View at: Publisher Site | Google ScholarJ. C. de Jongste, H. Mons, R. Van Strik, I. L. Bonta, and K. F. Kerrebijn, “Comparison of human bronchiolar smooth muscle responsiveness in vitro with histological signs of inflammation,” Thorax, vol. 42, no. 11, pp. 870–876, 1987.
View at: Google ScholarR. C. Jongejan, J. C. de Jongste, R. C. Raatgeep, T. Stijnen, I. L. Bonta, and K. F. Kerrebijn, “Effects of inflammatory mediators on the responsiveness of isolated human airways to methacholine,” American Review of Respiratory Disease, vol. 142, no. 5, pp. 1129–1132, 1990.
View at: Google ScholarI. L. Bonta, “Acupuncture beyond the endorphin concept?,” Medical Hypotheses, vol. 58, no. 3, pp. 221–224, 2002.
View at: Publisher Site | Google ScholarI. L. Bonta, “Schizophrenia, dissociative anaesthesia and near-death experience; three events meeting at the NMDA receptor,” Medical Hypotheses, vol. 62, no. 1, pp. 23–28, 2004.
View at: Publisher Site | Google Scholar